The high expression of LAT1 on BBB and glioma cells enabled these liposomes to cross the BBB more efficiently, enhancing drug delivery to the tumor site and improving therapeutic outcomes (Table 2) [87]. This evidence concerns the gene SLC7A5 and neoplasm.